This article was originally distributed via PRWeb. PRWeb, WorldNow and this Site make no warranties or representations in connection therewith.
An article published on January 1, 2014 on DiabetesDigest.com said that African Americans are getting diabetes at an increasingly high rate (1). polyDNA recommends Gene-Eden-VIR against the Epstein Barr Virus, which research shows may lead to diabetes.
Rochester, NY (PRWEB) February 19, 2014
polyDNA has learned that About 2.6 million African Americans or 11 percent of the African American community has diabetes and that 35-40% do not even know it (1). Researchers point out that diabetes is on the rise in the black community. Researchers point to two reasons why diabetes is on the rise in the African American community. The first is based on the observation that diabetes runs in families (1). The second is the Epstein Barr Virus. Research shows that the EBV might trigger the onset of diabetes. (See dlife.com, from May 2013) (2). polyDNA recommends Gene-Eden-VIR to African Americans. This natural antiviral was proven to reduce symptoms associated with EBV infections in a post-marketing clinical study that followed FDA guidelines.
Doctors usually recommend exercise, eating fiber, eating whole grains, losing extra weight, and making healthy food choices, when it comes to preventing diabetes. (See Advances in Virology, from January 13, 2012) (3). Most African Americans with diabetes are urged to exercise and lose weight. Studies show that African Americans are more likely to carry their excess weight above their waist which increases their risk of diabetesa lack of exercise (is) one significant factor contributing to the high rates of diabetes in African Americans (1).
However, in light of new research that linked EBV to diabetes, polyDNA recommends that Gene-Eden-VIR to African Americans with a family history of diabetes.
Other viruses were also linked to diabetes. An article reviewed by Dr. Jason C. Baker M.D. noted that Viruses that have been associated with type 1 diabetes as environmental triggers include coxsackie B, enteroviruses, adenovirus, rubella, cytomegalovirus, and Epstein-Barr virus (2).
With so many different viruses linked to diabetes, African Americans need a broad range product. Gene-Eden-VIR is such a product. Mike Evans, polyDNA
Because of the connection between viruses and diabetes, polyDNA recommends that African Americans ask their doctors about Gene-Eden-VIR, a natural, broad range, antiviral remedy that was proven to reduce viral symptoms in a post-marketing clinical study that followed FDA guidelines.
A study published on August 12, 2013 in the peer reviewed, medical journal Pharmacology & Pharmacy, in a special edition on Advances in Antiviral Drugs, showed that Gene-Eden-VIR reduced viral symptoms. Study authors wrote that, We observed a statistically significant decrease in the severity, duration, and frequency of symptoms (4).
To learn more about Gene-Eden-VIR, visit http://gene-eden-kill-virus.com/.
All orders of Gene-Eden-VIR are completely confidential, and no information is shared or sold to any third party. Privacy is assured.
(1) African Americans and Diabetes. Published on January 1, 2014.
(2) dlife.com - Type 1 Causes. Last reviewed on May 2013.
(3) Epstein-barr virus as a trigger of autoimmune liver diseases. Published in 2012.
(4) Gene-Eden-VIR Is Antiviral: Results of a Post Marketing Clinical Study. Published on August 12, 2013.
polyDNA is a biotechnology company that develops dietary supplements using the unique scientific method developed by Dr. Hanan Polansky, which is based on Computer Intuition.
In addition to his unique scientific method, Dr. Polansky published the highly acclaimed scientific discovery, called Microcompetition with Foreign DNA. The discovery explains how foreign DNA fragments, and specifically, DNA of latent viruses, cause most major diseases.
polyDNA developed Gene-Eden-VIR, an antiviral natural remedy that helps the immune system kill latent viruses.
For the original version on PRWeb visit: http://www.prweb.com/releases/2014/02/prweb11589258.htm
Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact firstname.lastname@example.org.